Follow Expert Insight, Commentary, and Intelligence On...

Latest Updates

Biosimilar Market Updates

During the first weeks of 2019 a number of biosimilar developers announced updates regarding their plans for the future. Bio-Thera Solutions Partners with Cipla for Bevacizumab Biosimilar Candidate - On January 14, 2019… more

Your law firm through the financial lens

The following piece was authored by Ariela Tannenbaum, Chief Financial Officer, Wilson Sonsini Goodrich & Rosati * for the Ark Group publication Business Intelligence and Analytics for Law Firms: Insights for a shifting business… more

When Redactions Don’t Redact

The press has widely reported on Paul Manafort’s attorneys’ failed attempt to redact sensitive information in a recent legal filing, allowing the press to uncover and publish the very information the attorneys intended to redact. The… more

H-1B Employment Visa Lottery for 2019!

On April 1, 2019, U.S. Citizenship and Immigration Services (USCIS) will start accepting H-1B visa petitions for the next fiscal year with a start date of October 1, 2019. The H-1B program allows companies in the United States to… more

The Shutdown: USCIS and E-Verify

The current government shutdown does not affect the vast majority of USCIS’s activities. Their offices are open, and interviews and appointments are proceeding as normal. USCIS continues to accept petitions and applications for benefit… more

IRS Relief for the Under-Withheld

For some taxpayers who miscalculated their withholding and/or estimated tax payments for 2018, the IRS is providing some relief. The new waiver provides that taxpayers will not be penalized under Section 6654 of the tax code if their… more

The Buzz About Block Grants

With the recent scoop from Politico that the Trump Administration is considering giving states the ability to implement Medicaid block grants, there has been considerable speculation on what the Administration is planning. Although we… more

Watch This

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.